Indication: Melanoma
Title: Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Newly Diagnosed or Recurrent Advanced Melanoma
Drug: Selinexor

Please visit clinicaltrials.gov to learn more about this trial

Phase IPhase IIPhase III
Phase I
Phase II
Phase III